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19th CardioVascular Summit: TCTAP 2014regimens except for Nicorandil. There was not much hemodynamic alteration with
200mgNitroglycerin. The incidence of side effects ofNitroglycerin such as headachewas
also rare. In general, the combination ofNitroglycerin andCalciumChannel Blockerwas
better than either Nitroglycerin or Nicorandil in preventing the spasm of radial artery.
Verapamil 2.5mg used in combination with Nitroglycerin 200mg is better in preventing
radial artery spasm than combination ofDiltiazem 5mg andNitroglycerin 200mg. Rashes
and vasovagal phenomenon was seen to occur more commonly with Diltiazem.
Conclusion: The occurrence of radial artery spasm during transradial coronary
angiography is prevented by intraarterial injection of Nitroglycerin with or without
calcium channel blocker. The best regimen to prevent spasm of radial artery in an ideal
patient is the combination of 200mg of Nitroglycerin with 2.5mg of Verapamil.
Nicorandil was less effective in preventing radial artery spasm.
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Background: Transradial intervention (TRI) is drastically increasing in every inter-
vention society around the world because of lower incidence of major bleeding and
vascular complications compared with trans-femoral intervention (TFI). However,
there have been limited data regarding clinical outcomes of TRI versus TFI in ST
elevation myocardial infarction (STEMI) patients (pts) in Asian population.
Methods: A total of 689 consecutive STEMI pts from nine major hospitals were
enrolled from Jan to Dec 2009. Cumulative major clinical outcomes up to 12 months
were compared between TRI (n¼220, 31.9%) and TFI group (n¼469, 28.1%).
Results: Baseline characteristics showed that TRI group had more smokers and a
higher incidence of hypertension, diabetes mellitus and previous cerebrovascular ac-
cidents whereas TFI group had a higher incidence of multi-vessel disease, left
circumﬂex lesion, type B2 or C lesion and chronic total occlusion. TRI group had a
lower incidence of major and minor hemorrhage during admission. Clinical outcomes
up to 12 months showed that the incidence of recurrent myocardial infarction, target
lesion revascularization (TLR) and target vessel revascularization (TVR) were lower
in the TRI group. Propensity score matched analysis showed that TRI was an inde-
pendent predictor of reducing TVR (OR: 0.08 95% CI: 0.01-0.67, p Value¼0.019),
MACE (OR: 0.37, 95% CI: 0.15-0.86, p Value¼0.022), and MACCE (OR: 0.33, 95%
CI: 0.14-0.76, p Value¼0.010) at 12 months.
Conclusion: In our study, TRI in STEMI pts undergoing primary PCI with DES was
associated with lower 12-months TVR, MACE and MACCE. We suggest that TRI
may play an important role in improving mid-term major clinical outcomes of STEMI
pts undergoing PCI with DESs.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POST
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Background: Transradial access (TRA) for percutaneous coronary intervention and
diagnostic coronary angiography has become an emerging trend in the routine practice
in most catheterization laboratory as it reduces the incidence of major access site
complications such as bleeding and haematoma. Radial artery spasm and perforation
are the main reasons for converting a procedure to femoral access. We prospectively
investigate the use of Sheathless EauCath (Asahi Intecc, Aichi, Japan) in cases of
radial artery spasm and perforation.
Methods: From Jan 2011 till Oct 2013, all patients with angiographically documented
radial artery spasm with or without perforation and failure of conventional 5 or 6 Fr
diagnostic or guiding catheters to cross the artery despite of repeated intra-arterial
nitroglycerin and/or verapamil were elected to attempt for Sheathless EauCath. The
procedural success, angiography of the forearm post procedure and access site out-
comes were evaluated.
Results: 36 patients, amean age of 619 yrswith 64%male, had signiﬁcant radial artery
spasm (n¼25, 69%) or perforation+spasm (n¼11, 31%) fulﬁlled the criteria for the use
of Sheathless EauCath. Procedural indications are stable angina in 18%, unstable angina
in 3%, non-ST elevation myocardial infarction (NSTEMI) in 54%, ST-elevation
myocardial infarction (STEMI) in 15% and 10% for other diagnostic procedures. 6.5 Fr
Sheathless EauCathwas used in 34 patients (94%) and 7.5 Frwas used in the remaining 2
patients (6%). The Sheathless EauCath was able to overcome the spasm with or without
perforation in all caseswith all patients achieved a successful procedural outcome.Of the
11 patients who had perforation of the radial artery, 10 patients (91%) had post-proce-
dural angiography showed no extravasation of contrast. The remaining one patient who
had trivial residual contrast extravasation outside the radial artery was successfully
managed with pressure dressing without signiﬁcant complications. There was no case of
haematoma or access site related bleeding issues.
Conclusion: The Sheathless EauCath can be used safely to overcome the radial artery
spasm and perforation during transradial coronary intervention or diagnostic procedures.
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Background: The latest EuropeanSociety ofCardiologyguidelines for themanagement
of acute myocardial infarction (AMI) in patients with ST-segment elevation recommend
transradial coronary intervention (TRI) to reduce the risk of vascular complications. We
evaluated the feasibility of TRI in patients with AMI complicated by cardiac arrest.
Methods: We retrospectively evaluated 20 consecutive patients with AMI who
required an extracorporeal membrane oxygenator (ECMO) because of cardiopulmo-
nary arrest resistant to conventional cardiopulmonary resuscitation. Percutaneous
access sites and evaluation criteria, including onset-to-ECMO time, door-to-balloon
time, and 30-day survival, were investigated.
Results: TRI was performed in 13 patients, whereas the other 7 patients underwent
transfemoral coronary intervention (TFI). No signiﬁcant differences in onset-to-
admission time (mean  SD: 26.8  14.6 vs. 17.0  13.3 min), onset-to-ECMO time
(41.8  18.8 vs. 39.0  16.6 min), and door-to-balloon time (61.4  19.1 vs. 79.3 ER/Transradial Intervention S35
